Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients
- Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event. van Wijk, I; Koudstaal, P J; Kappelle, L J; van Gijn, J; Gorter, J W; Algra, A // Journal of Neurology, Neurosurgery & Psychiatry;Aug2008, Vol. 79 Issue 8, p895
Background and aim: Published data suggest that patients with cerebral ischaemia and atrial fibrillation (CIAF( have higher inhospital mortality than patients with cerebral ischaemia of arterial origin (CIAO(. Data on long term risks are scarce. We compared the long term risks of death and...
- Association of the Adiponectin Gene Variations with Risk of Ischemic Stroke in a Korean Population. // Yonsei Medical Journal;1/1/2011, Vol. 52 Issue 1, p20
No abstract available.
- lschaemic stroke subtypes and associated risk factors: a French population based study. Bejot, Y.; Caillier, M.; Salem, D. Ben; Couvreur, G.; Rouaud, O.; Osseby, G-V.; Durier, J.; Marie, C.; Moreau, T.; Giroud, M. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2008, Vol. 79 Issue 12, p1344
Background: There is little reliable population based information about the distribution of risk factors among the various ischaemic stroke subtypes, even though determining risk factor profiles is of major importance to develop targeted preventive strategies. Methods: The distribution of first...
- Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. Wei-Wei Zhang; Chun-Yu Liu; Yan-Jiang Wang; Zhi-Qiang Xu; Yang Chen; Hua-Dong Zhou // Journal of Neurology;Sep2009, Vol. 256 Issue 9, p1493
Limited information is available on the relationship between metabolic syndrome and stroke in the Chinese population. The aim of this study was to establish the prevalence of metabolic syndrome in the Chinese population and the relationship between stroke and metabolic syndrome in that...
- Stroke risk estimation across nine European countries in the MORGAM project. Borglykke, Anders; Andreasen, Anne H.; Kuulasmaa, Kari; Sans, Susana; Ducimeti�re, Pierre; Vanuzzo, Diego; Ferrario, Marco M.; Palmieri, Luigi; Karvanen, Juha; Tunstall-Pedoe, Hugh; J�rgensen, Torben // Heart;Dec2010, Vol. 98 Issue 24, p1997
Background Previous tools for stroke risk assessment have either been developed for specific populations or lack data on non-fatal events or uniform data collection. The purpose of this study was to develop a stepwise model for the estimation of 10?ï¿½year risk of stroke in nine different...
- Aphasia assessment and functional outcome prediction in patients with aphasia after stroke. Gialanella, Bernardo // Journal of Neurology;Feb2011, Vol. 258 Issue 2, p343
vailable studies did not clarify whether a language examination may predict functional and motor outcome in patients with aphasia undergoing rehabilitation. This was the aim of the current study. Language examination considered in this study was the Aachen Aphasia Test (AAT). One hundred...
- Erratum to: The usefulness of albumin-adjusted ischemia-modified albumin index as early detecting marker for ischemic stroke. Ahn, Jung; Choi, Sang; Lee, Wee; Jung, Yoon // Neurological Sciences;Apr2011, Vol. 32 Issue 2, p367
No abstract available.
- Early severe hypoalbuminemia is an independent risk factor for intestinal failure in gastroschisis. Snyder, Christopher; Biggio, Joseph; Bartle, Donna; Georgeson, Keith; Muensterer, Oliver // Pediatric Surgery International;Nov2011, Vol. 27 Issue 11, p1155
Objective: This study attempted to evaluate the association of early hypoalbuminemia with the risk of intestinal failure in gastroschisis patients. Patients and methods: Neonates with gastroschisis treated at a tertiary children's hospital over a 10-year period were initially categorized into...
- RESEARCH BRIEF: Statins reduce the risk of stroke. // GP: General Practitioner;3/8/2004, p10
A five-year Great Britain study involving 20,536 patients at a high risk of stroke found that patients taking 40 mg simvastatin daily had a 25 percent lower stroke risk, compared to those who were taking placebo. The risk of ischaemic stroke was reduced by 30 percent.